AVBP – arrivent biopharma, inc. (US:NASDAQ)
Stock Stats
News
ArriVent BioPharma, Inc. (NASDAQ: AVBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
ArriVent BioPharma Reports First Quarter 2024 Financial Results [Yahoo! Finance]
ArriVent BioPharma Reports First Quarter 2024 Financial Results
ArriVent BioPharma, Inc. (NASDAQ: AVBP) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $25.00 price target on the stock.
ArriVent Appoints Kristine Peterson to its Board of Directors
Form 10-Q ArriVent BioPharma, Inc. For: Mar 31
Form 8-K ArriVent BioPharma, Inc. For: May 08
Form 3 ArriVent BioPharma, Inc. For: Apr 20 Filed by: Peterson Kristine
Form 4 ArriVent BioPharma, Inc. For: Apr 22 Filed by: Peterson Kristine
Form 8-K ArriVent Biopharma, Inc. For: Apr 20
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.